ENFN(Delisted)
EnfusionยทNYSE
--
--(--)
ENFN fundamentals
Enfusion (ENFN) expects to report earnings on May 8, 2025, with estimated revenue of 54.92M (YoY +14.18%), and EPS at 0.06 (YoY 0.00%).
Revenue estimate / YoY
54.92M
+14.18%
EPS estimate / YoY
0.06
0.00%
Report date
May 8, 2025
EPS
Revenue
Revenue & Expenses
ENFN has released its 2024 Q4 earnings report, with revenue of 52.94M, reflecting a YoY change of 13.88%, and net profit of 172.00K, showing a YoY change of -80.89%. The Sankey diagram below clearly presents ENFN's revenue sources and cost distribution.
Key Indicators
Enfusion (ENFN) key financial stats and ratios, covering profitability, financial health, and leverage.
Enfusion (ENFN)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Enfusion (ENFN)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Enfusion (ENFN)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Enfusion (ENFN) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Enfusion (ENFN) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
No Data
